I have just posted an update on the ongoing Avastin vs Lucentis battle.
Editors from Executive Laser Report (my former newsletter, now
published by Trends in Medicine) learned at the recent American Academy
of Ophthalmology meeting in Las Vegas, that some pharmaceutical and
device companies are allegedly attempting to stop or prevent the
recently announced head-to-head clinical trial of Avastin vs Lucentis
for treating age-related macular degeneration, sponsored by NEI/NIH.
The story is published in the November 30th issue of Executive Laser
Report.

I have received permission to reprint the story.
For all of the details, please take a look at my web Journal posting:

Avastin/Lucentis Update 9: A Disturbing Report about the Upcoming Trial
Between Avastin and Lucentis (December 2006)

http://irvaronsjournal.blogspot.com/2006/12/avastinlucentis-update-9-disturbing.html

Irv Arons